CRISPR THERAPEUTICS AG NAMEN AKT is a security (CUSIP H17182908) tracked across SEC portfolio filings. 5 institutional managers reported $29.3M on Form 13F as of 2026-06-30.
| Manager | Location | Value | Shares |
|---|---|---|---|
| IMC-Chicago, LLC | CHICAGO, IL | $16.7M | — |
| GROUP ONE TRADING, L.P. | CHICAGO, IL | $8.2M | — |
| SIMPLEX TRADING, LLC | CHICAGO, IL | $3.0M | — |
| JPMORGAN CHASE & CO | NEW YORK, NY | $1.4M | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | — |